Accuray (ARAY) Stock Forecast & Price Target

Accuray Inc. demonstrates a positive outlook largely due to its commitment to enhancing Service revenue, which has shown robust growth, increasing by 4% year-over-year. The company has also experienced strong contract revenue growth of 10% year-over-year, suggesting a strong demand for its technologically advanced radiation therapy solutions, particularly The CyberKnife system. Improved revenue growth and profitability are leading to heightened investor sentiment, indicating confidence in Accuray's financial trajectory moving forward.

Accuray Inc's recent financial reports indicate a concerning decline in product revenue, with figures of $37.2 million falling short of expectations, largely due to geopolitical pressures in regions such as EIMEA and China. The company has also reported significantly reduced orders and shipments, particularly from its joint venture in China, which delivered only 11 systems in F2Q26 compared to 27 in F2Q25. Furthermore, a negative impact on EBITDA of approximately $4 million, exacerbated by geographic mix and joint venture accounting affecting product gross margins, has led management to lower their revenue forecasts for the remainder of FY26, reflecting broader concerns about future order stability and growth.